Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant Formula | 6 | 2026 | 20 | 3.110 |
Why?
|
| Enteral Nutrition | 8 | 2025 | 104 | 1.860 |
Why?
|
| Child Nutrition Disorders | 3 | 2019 | 13 | 1.760 |
Why?
|
| Infant, Premature | 4 | 2026 | 305 | 1.740 |
Why?
|
| Infant | 23 | 2026 | 3328 | 1.650 |
Why?
|
| Child Development | 4 | 2025 | 179 | 1.490 |
Why?
|
| Nutritional Status | 8 | 2020 | 83 | 1.420 |
Why?
|
| Nutrition Assessment | 4 | 2025 | 23 | 1.370 |
Why?
|
| Food, Formulated | 4 | 2025 | 25 | 1.310 |
Why?
|
| United States Food and Drug Administration | 3 | 2026 | 164 | 1.300 |
Why?
|
| Malnutrition | 4 | 2018 | 39 | 1.200 |
Why?
|
| Refeeding Syndrome | 2 | 2019 | 3 | 1.170 |
Why?
|
| Infant Nutritional Physiological Phenomena | 2 | 2026 | 21 | 1.170 |
Why?
|
| Anthropometry | 3 | 2019 | 77 | 1.170 |
Why?
|
| Parenteral Nutrition | 6 | 2024 | 64 | 1.150 |
Why?
|
| Child, Preschool | 20 | 2025 | 4001 | 1.120 |
Why?
|
| Micronutrients | 3 | 2019 | 18 | 1.000 |
Why?
|
| Trace Elements | 3 | 2019 | 13 | 0.990 |
Why?
|
| Child | 28 | 2025 | 7681 | 0.970 |
Why?
|
| Food Safety | 1 | 2026 | 1 | 0.950 |
Why?
|
| Nutrition Policy | 1 | 2026 | 13 | 0.940 |
Why?
|
| Yogurt | 1 | 2025 | 2 | 0.920 |
Why?
|
| Marketing | 1 | 2026 | 24 | 0.920 |
Why?
|
| Catheter-Related Infections | 1 | 2025 | 26 | 0.910 |
Why?
|
| Diet | 3 | 2025 | 469 | 0.870 |
Why?
|
| Bacteremia | 1 | 2025 | 111 | 0.840 |
Why?
|
| Breast Feeding | 1 | 2026 | 113 | 0.840 |
Why?
|
| Catheterization, Central Venous | 1 | 2025 | 114 | 0.840 |
Why?
|
| Gastroenterology | 3 | 2020 | 162 | 0.810 |
Why?
|
| Short Bowel Syndrome | 4 | 2017 | 38 | 0.750 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2023 | 86 | 0.750 |
Why?
|
| Cronobacter | 1 | 2022 | 1 | 0.740 |
Why?
|
| Cronobacter sakazakii | 1 | 2022 | 2 | 0.740 |
Why?
|
| Infant, Newborn | 9 | 2026 | 2529 | 0.720 |
Why?
|
| Hypophosphatemia | 2 | 2019 | 10 | 0.700 |
Why?
|
| Selenium | 1 | 2021 | 46 | 0.680 |
Why?
|
| Exocrine Pancreatic Insufficiency | 2 | 2019 | 11 | 0.650 |
Why?
|
| Vitamins | 2 | 2019 | 93 | 0.650 |
Why?
|
| Hyperglycemia | 2 | 2019 | 186 | 0.620 |
Why?
|
| Intestinal Absorption | 3 | 2009 | 125 | 0.610 |
Why?
|
| Humans | 48 | 2026 | 98080 | 0.580 |
Why?
|
| Fanconi Syndrome | 1 | 2018 | 3 | 0.560 |
Why?
|
| Chromium | 1 | 2017 | 17 | 0.540 |
Why?
|
| Glucose | 2 | 2018 | 704 | 0.530 |
Why?
|
| Arm | 1 | 2018 | 99 | 0.520 |
Why?
|
| Nutritional Support | 2 | 2017 | 20 | 0.510 |
Why?
|
| Milk, Human | 3 | 2026 | 54 | 0.490 |
Why?
|
| Growth | 3 | 2001 | 42 | 0.490 |
Why?
|
| Avitaminosis | 2 | 2019 | 5 | 0.460 |
Why?
|
| Dietary Fats | 3 | 2026 | 135 | 0.460 |
Why?
|
| Probiotics | 2 | 2025 | 99 | 0.450 |
Why?
|
| Crohn Disease | 4 | 2022 | 844 | 0.420 |
Why?
|
| Nutritional Requirements | 3 | 2026 | 17 | 0.390 |
Why?
|
| United States | 7 | 2026 | 8197 | 0.380 |
Why?
|
| End Stage Liver Disease | 1 | 2013 | 77 | 0.360 |
Why?
|
| Mesalamine | 2 | 2005 | 90 | 0.350 |
Why?
|
| Failure to Thrive | 2 | 2002 | 17 | 0.340 |
Why?
|
| Adolescent | 14 | 2025 | 10080 | 0.330 |
Why?
|
| Diarrhea | 2 | 2018 | 180 | 0.330 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 255 | 0.320 |
Why?
|
| Choline Deficiency | 1 | 2010 | 4 | 0.310 |
Why?
|
| Choline | 1 | 2010 | 23 | 0.310 |
Why?
|
| Malabsorption Syndromes | 1 | 2009 | 21 | 0.300 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2021 | 51 | 0.300 |
Why?
|
| Digestive System Diseases | 1 | 2009 | 19 | 0.300 |
Why?
|
| Growth Disorders | 2 | 2019 | 64 | 0.300 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2009 | 7 | 0.300 |
Why?
|
| Methylmalonic Acid | 1 | 2009 | 7 | 0.300 |
Why?
|
| Electrolytes | 2 | 2019 | 57 | 0.290 |
Why?
|
| Intestines | 2 | 2009 | 441 | 0.280 |
Why?
|
| Body Composition | 2 | 2018 | 88 | 0.280 |
Why?
|
| Reference Values | 2 | 2019 | 608 | 0.260 |
Why?
|
| Amino Acids | 3 | 2023 | 246 | 0.260 |
Why?
|
| Energy Metabolism | 2 | 2019 | 315 | 0.260 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2009 | 220 | 0.250 |
Why?
|
| Male | 21 | 2025 | 47076 | 0.250 |
Why?
|
| Food Additives | 1 | 2026 | 3 | 0.240 |
Why?
|
| Nutritive Value | 1 | 2026 | 7 | 0.240 |
Why?
|
| Food Contamination | 1 | 2026 | 37 | 0.230 |
Why?
|
| Hypervitaminosis A | 1 | 2005 | 2 | 0.230 |
Why?
|
| Lactobacillus | 1 | 2025 | 26 | 0.230 |
Why?
|
| Vitamin A | 1 | 2005 | 29 | 0.230 |
Why?
|
| Central Venous Catheters | 1 | 2025 | 24 | 0.220 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2026 | 74 | 0.220 |
Why?
|
| Diagnosis, Differential | 5 | 2019 | 1567 | 0.220 |
Why?
|
| Fatty Acids | 1 | 2026 | 147 | 0.220 |
Why?
|
| Female | 21 | 2026 | 51536 | 0.220 |
Why?
|
| Feces | 3 | 2019 | 387 | 0.220 |
Why?
|
| Rehydration Solutions | 1 | 2004 | 4 | 0.210 |
Why?
|
| Dehydration | 1 | 2004 | 22 | 0.210 |
Why?
|
| Milk | 3 | 2020 | 56 | 0.210 |
Why?
|
| Gastroenteritis | 1 | 2004 | 26 | 0.210 |
Why?
|
| Dietary Supplements | 1 | 2005 | 152 | 0.210 |
Why?
|
| Pneumonia | 1 | 2005 | 195 | 0.200 |
Why?
|
| Insulin | 2 | 2019 | 1225 | 0.200 |
Why?
|
| Pancreatic Elastase | 2 | 2019 | 15 | 0.200 |
Why?
|
| Fluid Therapy | 1 | 2004 | 105 | 0.200 |
Why?
|
| Dietary Fiber | 1 | 2023 | 46 | 0.190 |
Why?
|
| Endodermal Sinus Tumor | 1 | 2002 | 3 | 0.180 |
Why?
|
| Liver | 2 | 2023 | 1231 | 0.180 |
Why?
|
| Constipation | 2 | 2023 | 68 | 0.180 |
Why?
|
| Pelvic Neoplasms | 1 | 2002 | 43 | 0.180 |
Why?
|
| Exercise | 1 | 2025 | 380 | 0.180 |
Why?
|
| Body Mass Index | 2 | 2018 | 850 | 0.170 |
Why?
|
| Teratoma | 1 | 2002 | 56 | 0.170 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2021 | 26 | 0.170 |
Why?
|
| Powders | 1 | 2022 | 88 | 0.170 |
Why?
|
| Pancreas | 2 | 2019 | 269 | 0.170 |
Why?
|
| Societies | 1 | 2020 | 15 | 0.160 |
Why?
|
| Body Weight | 3 | 2013 | 455 | 0.160 |
Why?
|
| Vitamin D | 1 | 2002 | 286 | 0.160 |
Why?
|
| Steatorrhea | 1 | 2019 | 2 | 0.150 |
Why?
|
| Trypsinogen | 1 | 2019 | 4 | 0.150 |
Why?
|
| Magnesium Deficiency | 1 | 2019 | 5 | 0.150 |
Why?
|
| Ectodermal Dysplasia | 1 | 2019 | 2 | 0.150 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2019 | 7 | 0.150 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2019 | 4 | 0.150 |
Why?
|
| Pancreatic Function Tests | 1 | 2019 | 8 | 0.150 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2019 | 9 | 0.150 |
Why?
|
| Rest | 1 | 2000 | 52 | 0.150 |
Why?
|
| Anus, Imperforate | 1 | 2019 | 10 | 0.150 |
Why?
|
| Thiamine Deficiency | 1 | 2019 | 4 | 0.150 |
Why?
|
| Chymotrypsin | 1 | 2019 | 29 | 0.150 |
Why?
|
| Hypokalemia | 1 | 2019 | 21 | 0.150 |
Why?
|
| Starvation | 1 | 2019 | 22 | 0.150 |
Why?
|
| Mitochondrial Diseases | 1 | 2019 | 16 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2022 | 677 | 0.150 |
Why?
|
| Pancreatic Diseases | 1 | 2019 | 61 | 0.150 |
Why?
|
| Muscular Diseases | 1 | 2019 | 66 | 0.150 |
Why?
|
| Pain | 1 | 2002 | 416 | 0.150 |
Why?
|
| Nose | 1 | 2019 | 97 | 0.150 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2019 | 56 | 0.150 |
Why?
|
| Retrospective Studies | 6 | 2021 | 10973 | 0.140 |
Why?
|
| Cerebral Palsy | 1 | 2019 | 100 | 0.140 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 1998 | 9 | 0.140 |
Why?
|
| Disability Evaluation | 1 | 2019 | 186 | 0.140 |
Why?
|
| Enema | 1 | 1998 | 37 | 0.140 |
Why?
|
| Pancreatitis, Chronic | 1 | 2019 | 89 | 0.140 |
Why?
|
| Pericarditis | 1 | 1998 | 14 | 0.140 |
Why?
|
| Physical Examination | 1 | 2019 | 149 | 0.140 |
Why?
|
| Aminoglycosides | 1 | 2018 | 31 | 0.140 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 123 | 0.140 |
Why?
|
| Intestinal Perforation | 1 | 1998 | 38 | 0.140 |
Why?
|
| Drug Hypersensitivity | 1 | 1998 | 38 | 0.140 |
Why?
|
| Sodium | 1 | 2019 | 330 | 0.140 |
Why?
|
| Intellectual Disability | 1 | 2019 | 202 | 0.140 |
Why?
|
| Urinalysis | 1 | 2018 | 34 | 0.140 |
Why?
|
| Colitis, Ulcerative | 2 | 2022 | 824 | 0.130 |
Why?
|
| Celiac Disease | 1 | 2001 | 229 | 0.130 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 60 | 0.130 |
Why?
|
| World Health Organization | 1 | 2018 | 125 | 0.130 |
Why?
|
| Osteoporosis | 1 | 1999 | 135 | 0.130 |
Why?
|
| Aging | 1 | 2002 | 770 | 0.130 |
Why?
|
| Program Development | 1 | 2017 | 141 | 0.120 |
Why?
|
| Hypothyroidism | 1 | 2019 | 299 | 0.120 |
Why?
|
| Clostridium Infections | 1 | 2018 | 132 | 0.120 |
Why?
|
| Milk Proteins | 1 | 2016 | 24 | 0.120 |
Why?
|
| Milk Hypersensitivity | 1 | 2016 | 12 | 0.120 |
Why?
|
| Esophagitis | 2 | 2006 | 40 | 0.110 |
Why?
|
| Disease Management | 1 | 2017 | 377 | 0.110 |
Why?
|
| Eosinophilia | 2 | 2006 | 87 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2017 | 320 | 0.110 |
Why?
|
| Birth Weight | 2 | 2016 | 150 | 0.100 |
Why?
|
| Interleukin-12 Receptor beta 1 Subunit | 1 | 2013 | 2 | 0.100 |
Why?
|
| Candidiasis | 1 | 2013 | 40 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2017 | 911 | 0.100 |
Why?
|
| Dietary Proteins | 1 | 2013 | 31 | 0.100 |
Why?
|
| Dietary Carbohydrates | 1 | 2013 | 39 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 882 | 0.090 |
Why?
|
| Risk Factors | 2 | 2019 | 6233 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2013 | 1110 | 0.090 |
Why?
|
| HIV Infections | 1 | 2001 | 1018 | 0.080 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2011 | 22 | 0.080 |
Why?
|
| Food | 1 | 2011 | 93 | 0.080 |
Why?
|
| Antigens | 1 | 2011 | 225 | 0.080 |
Why?
|
| Body Height | 2 | 2000 | 109 | 0.080 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 70 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2009 | 239 | 0.070 |
Why?
|
| Drug Administration Schedule | 2 | 2018 | 839 | 0.070 |
Why?
|
| Acidosis | 1 | 2009 | 55 | 0.070 |
Why?
|
| Bacterial Translocation | 1 | 2008 | 26 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 1 | 2009 | 155 | 0.070 |
Why?
|
| Cattle | 2 | 2020 | 397 | 0.070 |
Why?
|
| Placebos | 1 | 2008 | 209 | 0.070 |
Why?
|
| Prevalence | 2 | 2002 | 1384 | 0.060 |
Why?
|
| Recurrence | 3 | 2013 | 1254 | 0.060 |
Why?
|
| Animals | 4 | 2020 | 28894 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2008 | 409 | 0.060 |
Why?
|
| Age Factors | 1 | 2010 | 1962 | 0.060 |
Why?
|
| Osmolar Concentration | 1 | 2004 | 166 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2001 | 2037 | 0.050 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2004 | 76 | 0.050 |
Why?
|
| Adult | 5 | 2013 | 29539 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2008 | 1782 | 0.050 |
Why?
|
| Plant Gums | 1 | 2023 | 2 | 0.050 |
Why?
|
| Galactans | 1 | 2023 | 3 | 0.050 |
Why?
|
| Mannans | 1 | 2023 | 6 | 0.050 |
Why?
|
| Menarche | 1 | 2022 | 32 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2004 | 198 | 0.050 |
Why?
|
| Sacrococcygeal Region | 1 | 2002 | 13 | 0.050 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2002 | 12 | 0.050 |
Why?
|
| Vitamin D Deficiency | 1 | 2002 | 119 | 0.040 |
Why?
|
| Anal Canal | 1 | 2002 | 94 | 0.040 |
Why?
|
| Seasons | 1 | 2002 | 251 | 0.040 |
Why?
|
| Perinatology | 1 | 2001 | 14 | 0.040 |
Why?
|
| Peptides | 1 | 2004 | 669 | 0.040 |
Why?
|
| Beverages | 1 | 2020 | 16 | 0.040 |
Why?
|
| Age Determination by Skeleton | 1 | 2000 | 12 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2002 | 370 | 0.040 |
Why?
|
| Puberty | 1 | 2000 | 59 | 0.040 |
Why?
|
| Medical Records | 1 | 2000 | 123 | 0.040 |
Why?
|
| Health Education | 1 | 2020 | 109 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2000 | 116 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2000 | 321 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2011 | 3212 | 0.040 |
Why?
|
| Universities | 1 | 2020 | 166 | 0.040 |
Why?
|
| Diphosphonates | 1 | 1999 | 36 | 0.040 |
Why?
|
| Abdomen, Acute | 1 | 1998 | 21 | 0.040 |
Why?
|
| Sulfasalazine | 1 | 1998 | 33 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 1998 | 296 | 0.030 |
Why?
|
| Prednisone | 1 | 1998 | 251 | 0.030 |
Why?
|
| Bone Density | 1 | 1999 | 248 | 0.030 |
Why?
|
| North America | 1 | 2017 | 210 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 674 | 0.030 |
Why?
|
| Sex Factors | 1 | 2000 | 1138 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2020 | 682 | 0.030 |
Why?
|
| Protein Hydrolysates | 1 | 2016 | 9 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 2666 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 1782 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 2784 | 0.020 |
Why?
|
| Patient Outcome Assessment | 1 | 2013 | 90 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 3022 | 0.020 |
Why?
|
| Seafood | 1 | 2011 | 11 | 0.020 |
Why?
|
| Eggs | 1 | 2011 | 14 | 0.020 |
Why?
|
| Antigens, Plant | 1 | 2011 | 14 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2011 | 82 | 0.020 |
Why?
|
| Esophagus | 1 | 2011 | 108 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2018 | 9711 | 0.020 |
Why?
|
| Remission Induction | 1 | 2011 | 754 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 1224 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2006 | 245 | 0.010 |
Why?
|
| Esophagoscopy | 1 | 2004 | 91 | 0.010 |
Why?
|
| Gastroesophageal Reflux | 1 | 2004 | 129 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1815 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 4025 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 29428 | 0.010 |
Why?
|